Francis Knuettel II

CFO, Treas & SectyPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed May 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$40K
Net Open-Market Flow
-$40K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 22, 2026Disposed to issuer(D)14K$020K
May 22, 2026Sell(S)2K$26.84$40K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 22, 2026Grant(A)60K60K
May 22, 2026Disposed to issuer(D)43K0

Transaction Codes

D
Disposition to the issuer
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001919246-26-000081) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.